The Patent Finder
US

Systems and Methods for the Treatment of Pain Through Neural Fiber Stimulation

US 8,788,047 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Mar 10, 2020 (The Director of the Ohio Development Services Agency).

Term ends Dec 7, 2029 · High confidence

Filed Dec 1, 2011 as application 13/309,107 · Granted Jul 22, 2014
Base term, 20 years from filing
Today
20 years from filing
2009 2029
Clock starts
Dec 7, 2009
Term ends
Dec 7, 2029
Granted
Jul 22, 2014
base term fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,788,046, to Dec 7, 2029. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
47
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 7, 2009, when application 12/653,029, the earliest non-provisional in its chain, was filed (this one was filed Dec 1, 2011)Dec 7, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,788,046)resolves to Dec 7, 2029, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 7, 2029High confidence

Partial family

US 8,463,383In force
Jul 2031
Jul 2031
US 8,954,153In force
Mar 2031
Mar 2031
Application 12/653,029Abandoned
not computed
not computed
Application 13/095,616No file history here
not computed
not computed
US 10,668,285In force
Dec 2029
Dec 2029
US 8,788,046In force
Dec 2029
Dec 2029
US 8,788,047this patent
Dec 2029
Dec 2029
US 8,788,048In force
Dec 2029
Dec 2029
8 of 47 applications in this family shown, earliest filings first. Partial: 2 of the 47 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 4, 2012
Reel 27985, frame 226
Bennett, Maria E.; Boggs, Joseph W., II; Grill, Warren M.; Chae, JohnSPR Therapeutics, LLCAssignment of Assignor's Interest
May 30, 2013
Reel 30518, frame 830
SPR Therapeutics, LLCThe Director of the Ohio Development Services AgencySecurity Agreement
Sep 24, 2014
Reel 33809, frame 771
SPR Therapeutics, LLCOhio Development Services AgencySecurity Interest
Nov 9, 2017
Reel 44715, frame 395
SPR Therapeutics, Inc.The Director of the Ohio Development Services AgencySecurity Interest
Dec 6, 2017
Reel 44716, frame 812
SPR Therapeutics, LLCSPR Therapeutics, Inc.Change of Name
Oct 15, 2019
Reel 50728, frame 721
The Director of the Ohio Development Services AgencySPR Therapeutics, Inc.Release of Security Interest
Mar 10, 2020
Reel 52137, frame 516
SPR Therapeutics, LLCThe Director of the Ohio Development Services AgencyCorrective Assignment to Correct the the Properties Listed in the Security Interest Previously Recorded at Reel: 030518 Frame: 0830. Assignor(S) Hereby Confirms the Assignment.
Jan 30, 2024
Reel 66381, frame 75
SPR Therapeutics, Inc.SLR Investment Corp., as AgentIntellectual Property Security Agreement
Jan 30, 2024
Reel 66412, frame 400
SPR Therapeutics, Inc.Gemino Healthcare Finance, LLCSecurity Interest
Feb 8, 2024
Reel 66526, frame 25
The Director of Development, State of Ohio, Formerly Known as the Director of the Ohio Development Services AgencySPR Therapeutics, Inc., Formerly Known as SPR Therapeutics, LLCRelease of Security Interest
Jul 15, 2026
Reel 75985, frame 374
Gemino Healthcare Finance, LLC, D/B/A SLR Healthcare ABLSPR Therapeutics, Inc.Release of Security Interest
Jul 15, 2026
Reel 75985, frame 409
SLR Investment Corp., as AgentSPR Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited